Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammography | 11 | 2019 | 271 | 2.100 |
Why?
|
| Early Detection of Cancer | 9 | 2019 | 267 | 1.770 |
Why?
|
| Telephone | 10 | 2019 | 115 | 1.770 |
Why?
|
| Counseling | 10 | 2019 | 350 | 1.560 |
Why?
|
| Reminder Systems | 4 | 2019 | 72 | 1.100 |
Why?
|
| Colorectal Neoplasms | 8 | 2015 | 263 | 0.930 |
Why?
|
| Patient Acceptance of Health Care | 7 | 2013 | 454 | 0.850 |
Why?
|
| Patient Compliance | 4 | 2019 | 349 | 0.790 |
Why?
|
| Health Literacy | 4 | 2015 | 78 | 0.670 |
Why?
|
| Health Knowledge, Attitudes, Practice | 9 | 2013 | 725 | 0.650 |
Why?
|
| Comprehension | 4 | 2015 | 131 | 0.630 |
Why?
|
| Mass Screening | 8 | 2015 | 652 | 0.610 |
Why?
|
| Health Promotion | 5 | 2019 | 471 | 0.600 |
Why?
|
| Guideline Adherence | 1 | 2019 | 296 | 0.550 |
Why?
|
| Breast Neoplasms | 8 | 2019 | 1118 | 0.520 |
Why?
|
| Reading | 2 | 2012 | 92 | 0.450 |
Why?
|
| Health Education | 3 | 2010 | 183 | 0.430 |
Why?
|
| SEER Program | 1 | 2012 | 66 | 0.380 |
Why?
|
| Prostatic Neoplasms | 2 | 2015 | 339 | 0.370 |
Why?
|
| Psychometrics | 2 | 2015 | 362 | 0.370 |
Why?
|
| Community-Institutional Relations | 1 | 2011 | 37 | 0.360 |
Why?
|
| Survivors | 1 | 2012 | 150 | 0.360 |
Why?
|
| Aged | 21 | 2019 | 13426 | 0.350 |
Why?
|
| Men's Health | 1 | 2010 | 12 | 0.340 |
Why?
|
| Directive Counseling | 1 | 2010 | 38 | 0.340 |
Why?
|
| Patient Education as Topic | 3 | 2010 | 453 | 0.340 |
Why?
|
| Neoplasms | 4 | 2013 | 1233 | 0.330 |
Why?
|
| Middle Aged | 21 | 2019 | 16342 | 0.330 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 415 | 0.310 |
Why?
|
| Health Policy | 2 | 2017 | 177 | 0.290 |
Why?
|
| Research Design | 1 | 2011 | 556 | 0.290 |
Why?
|
| Decision Making | 2 | 2015 | 395 | 0.290 |
Why?
|
| Interprofessional Relations | 1 | 2008 | 129 | 0.270 |
Why?
|
| Health Behavior | 2 | 2008 | 452 | 0.270 |
Why?
|
| Teaching | 1 | 2008 | 152 | 0.270 |
Why?
|
| Surveys and Questionnaires | 3 | 2012 | 2516 | 0.250 |
Why?
|
| Primary Health Care | 3 | 2019 | 651 | 0.250 |
Why?
|
| Software | 2 | 2017 | 366 | 0.250 |
Why?
|
| Female | 22 | 2019 | 30779 | 0.250 |
Why?
|
| Models, Theoretical | 2 | 2008 | 256 | 0.230 |
Why?
|
| Computer-Assisted Instruction | 1 | 2005 | 77 | 0.230 |
Why?
|
| Aged, 80 and over | 7 | 2019 | 5128 | 0.220 |
Why?
|
| Clinical Competence | 1 | 2008 | 683 | 0.210 |
Why?
|
| Humans | 25 | 2019 | 59479 | 0.200 |
Why?
|
| Women's Health | 3 | 2011 | 360 | 0.180 |
Why?
|
| Educational Measurement | 2 | 2012 | 212 | 0.170 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 2341 | 0.160 |
Why?
|
| Cost-Benefit Analysis | 3 | 2019 | 299 | 0.160 |
Why?
|
| Pilot Projects | 3 | 2010 | 916 | 0.140 |
Why?
|
| Educational Status | 3 | 2013 | 264 | 0.140 |
Why?
|
| Male | 12 | 2015 | 27794 | 0.130 |
Why?
|
| Cohort Studies | 2 | 2019 | 2377 | 0.130 |
Why?
|
| Massachusetts | 6 | 2013 | 2023 | 0.120 |
Why?
|
| Tamoxifen | 1 | 2015 | 35 | 0.120 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2015 | 30 | 0.120 |
Why?
|
| Interviews as Topic | 2 | 2009 | 484 | 0.120 |
Why?
|
| Adult | 9 | 2019 | 15704 | 0.120 |
Why?
|
| United States | 5 | 2012 | 7431 | 0.110 |
Why?
|
| Patient Participation | 1 | 2015 | 216 | 0.100 |
Why?
|
| Focus Groups | 2 | 2010 | 288 | 0.090 |
Why?
|
| Program Evaluation | 3 | 2017 | 470 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 1561 | 0.090 |
Why?
|
| Managed Care Programs | 1 | 2011 | 88 | 0.090 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2010 | 12 | 0.090 |
Why?
|
| Prostate-Specific Antigen | 1 | 2010 | 66 | 0.080 |
Why?
|
| Referral and Consultation | 1 | 2013 | 405 | 0.080 |
Why?
|
| Mass Media | 1 | 2010 | 31 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1029 | 0.080 |
Why?
|
| Physicians, Primary Care | 1 | 2010 | 75 | 0.080 |
Why?
|
| Consensus | 1 | 2010 | 193 | 0.080 |
Why?
|
| Models, Psychological | 1 | 2009 | 94 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2013 | 526 | 0.080 |
Why?
|
| Group Processes | 1 | 2008 | 41 | 0.070 |
Why?
|
| Treatment Refusal | 1 | 2008 | 54 | 0.070 |
Why?
|
| Pamphlets | 1 | 2007 | 17 | 0.070 |
Why?
|
| Medical Records | 1 | 2007 | 133 | 0.070 |
Why?
|
| Government Programs | 1 | 2006 | 20 | 0.070 |
Why?
|
| Colonic Polyps | 1 | 2006 | 25 | 0.060 |
Why?
|
| Decision Trees | 1 | 2005 | 51 | 0.060 |
Why?
|
| Perception | 1 | 2006 | 168 | 0.060 |
Why?
|
| Community Health Services | 1 | 2006 | 120 | 0.060 |
Why?
|
| Medical History Taking | 1 | 2005 | 65 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 2383 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2005 | 487 | 0.060 |
Why?
|
| Program Development | 1 | 2005 | 203 | 0.060 |
Why?
|
| Data Collection | 1 | 2005 | 373 | 0.050 |
Why?
|
| Motivation | 1 | 2005 | 275 | 0.050 |
Why?
|
| Health Maintenance Organizations | 1 | 2003 | 59 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 677 | 0.050 |
Why?
|
| New England | 1 | 2003 | 267 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 706 | 0.040 |
Why?
|
| Physician-Patient Relations | 2 | 2015 | 399 | 0.040 |
Why?
|
| Effect Modifier, Epidemiologic | 1 | 2000 | 9 | 0.040 |
Why?
|
| Algorithms | 1 | 2005 | 979 | 0.040 |
Why?
|
| Georgia | 2 | 2012 | 87 | 0.040 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2019 | 24 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2005 | 1927 | 0.040 |
Why?
|
| Internet | 2 | 2013 | 449 | 0.040 |
Why?
|
| Genetic Privacy | 1 | 1997 | 4 | 0.040 |
Why?
|
| Insurance | 1 | 1997 | 18 | 0.030 |
Why?
|
| Health Plan Implementation | 1 | 2017 | 40 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2019 | 202 | 0.030 |
Why?
|
| Pedigree | 1 | 1997 | 183 | 0.030 |
Why?
|
| Genetic Testing | 1 | 1997 | 127 | 0.030 |
Why?
|
| Qualitative Research | 2 | 2010 | 619 | 0.030 |
Why?
|
| Telemedicine | 1 | 2019 | 310 | 0.030 |
Why?
|
| Information Seeking Behavior | 1 | 2013 | 36 | 0.030 |
Why?
|
| Hawaii | 1 | 2012 | 22 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 748 | 0.020 |
Why?
|
| Television | 1 | 2010 | 21 | 0.020 |
Why?
|
| Public Opinion | 1 | 2010 | 22 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 5293 | 0.020 |
Why?
|
| Appalachian Region | 1 | 2006 | 1 | 0.020 |
Why?
|
| New Mexico | 1 | 2006 | 9 | 0.020 |
Why?
|
| Colorado | 1 | 2006 | 19 | 0.020 |
Why?
|
| Michigan | 1 | 2006 | 41 | 0.020 |
Why?
|
| Florida | 1 | 2006 | 42 | 0.020 |
Why?
|
| Texas | 1 | 2006 | 56 | 0.020 |
Why?
|
| Demography | 1 | 2006 | 169 | 0.020 |
Why?
|
| Risk Factors | 2 | 2006 | 4991 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2006 | 742 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 439 | 0.010 |
Why?
|
| Physical Examination | 1 | 2003 | 104 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2003 | 245 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2002 | 678 | 0.010 |
Why?
|
| American Cancer Society | 1 | 1997 | 3 | 0.010 |
Why?
|
| Insurance Selection Bias | 1 | 1997 | 3 | 0.010 |
Why?
|
| Genetic Research | 1 | 1997 | 8 | 0.010 |
Why?
|
| Genetics | 1 | 1997 | 13 | 0.010 |
Why?
|
| Organizational Policy | 1 | 1997 | 47 | 0.010 |
Why?
|
| Confidentiality | 1 | 1997 | 52 | 0.010 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 1997 | 42 | 0.010 |
Why?
|
| Prejudice | 1 | 1997 | 60 | 0.010 |
Why?
|
| Informed Consent | 1 | 1997 | 138 | 0.010 |
Why?
|